Nanōmix has obtained CE mark for its Covid-19 rapid point-of-care (POC) antigen panel, which is used with the company’s eLab analyser.

The eLab Covid-19 antigen test cartridge provides results in 15 minutes using an anterior nasal swab.

Go deeper with GlobalData

Go deeper with GlobalData

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

It enables qualitative detection of the SARS-CoV-2 virus nucleocapsid antigen from the swabs.

Nanōmix chief commercial officer John Hardesky said: “Receiving the CE mark for our Covid-19 rapid antigen test is a key milestone, which further validates our rapid and accurate POC testing technology.

“This assay complements our S1 Critical Infection Panel which provides valuable insight to clinicians as they diagnose and monitor severe, co-infections, including those of Covid-19 patients.”

A swab and sample collection tube included with the panel are used to collect nasal swab samples, which are then transferred to the single-use, microfluidic cartridge.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

This cartridge is run on the Nanōmix eLab, which can print or send results electronically through Bluetooth.

The eLab system can also publish the test results output as a QR code, providing increased privacy.

Nanōmix president and CEO David Ludvigson said: “The Nanōmix eLab is a comprehensive diagnostic platform that has enormous potential in time-sensitive diagnostic applications.”

Federal funds from the Department of Health and Human Services, the Office of the Assistant Secretary for Preparedness and Response, and the Biomedical Advanced Research and Development Authority were used to fund the project in whole or in part.

Last February, Nanōmix submitted an Emergency Use Authorization request to the US Food and Drug Administration (FDA) for the portable, handheld eLab Covid-19 rapid antigen test.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
HemoSonics has won the 2025 Marketing Award for its impactful promotion of theQuantra Hemostasis System and leadership in blood management education. See how targeted campaigns, thought leadership content, and hands on clinician training are accelerating Quantra’s market traction and shaping the future of hemostasis testing.

Discover the Impact